Advertisement
Horizon Therapeutics To Buyback Up To $500 Mln Of Ordinary Shares
(RTTNews) - Biotechnology company Horizon Therapeutics plc (HZNP) today announced that its Board of Directors authorized the repurchase of up to $500 million of the Company's ordinary shares.
Under the program, the Company may repurchase ordinary shares from time to time on the open market or through privately negotiated transactions or structured repurchase transactions.
As of June 30, 2022, the Company had cash and cash equivalents of $1.89 billion. The Company expects to fund the repurchase of its ordinary shares under the program with existing cash and cash equivalents.
read more
Amgen, Horizon Therapeutics Reach Settlement On FTC Lawsuit; Seeks To Close Acquisition In Q4
Amgen (AMGN) and Horizon Therapeutics plc (HZNP) announced Friday the entry into a consent order agreement with the Federal Trade Commission (FTC) that resolves the pending FTC administrative lawsuit. This clears the path to take the final steps to close Amgen's $27.8 billion acquisition of Horizon.
RTTNews
|
Před 803 dny
Horizon Says UPLIZNA Approved By Brazilian Health Regulatory Agency As Monotherapy For NMOSD
Biotechnology company Horizon Therapeutics plc (HZNP) announced Tuesday that the Brazilian Health Regulatory Agency (ANVISA) has approved UPLIZNA as a monotherapy for the treatment of adult patients with NMOSD who are AQP4-IgG+.
RTTNews
|
Před 1058 dny
Xeris Biopharma Inks Research Collaboration With Horizon Therapeutics To Develop Teprotumumab
Biopharmaceutical company Xeris Biopharma Holdings, Inc. (XERS) announced Wednesday that it has entered into a research collaboration and option agreement with Horizon Therapeutics plc (HZNP).
RTTNews
|
Před 1085 dny
Horizon Says Phase 2 Trial Of Dazodalibep To Treat Sjögren's Syndrome Met Primary Endpoint
Horizon Therapeutics plc (HZNP) announced Monday that its Phase 2 trial evaluating dazodalibep for the treatment of Sjögren's syndrome met the primary endpoint in patients with moderate-to-high systemic disease activity. Sjögren's syndrome is a disease with no FDA-approved treatments available.
RTTNews
|
Před 1157 dny
CAC 40 Extends Gains To 3rd Straight Day, Rises Over 1%
French stocks are up in positive territory on Wednesday, extending gains to a third straight session, led by gains in financial and luxury sectors.
Expectations of an interest rate cut by the Federal Reserve next month, and hopes that the government shutdown in the U.S. will likely end this week help underpin sentiment.
RTTNews
|
Před 1 h 32 min
DAX Climbs To 4-week High On Inflation Data, Earnings
Germany's DAX climbed to a four-week high on Wednesday with investors continuing to pick up stocks amid hopes the US government shutdown will come to an end soon, and expectations of an interest rate cut by the Federal Reserve in December.
RTTNews
|
Před 1 h 58 min
Sensex, Nifty Surge On Trade Deal Hopes; IT Stocks Lead Gains
Indian shares rose notably on Wednesday, with U.S. shutdown resolution and growing optimism over a potential trade deal with the United States boosting sentiment.
RTTNews
|
Před 2 h 56 min
Yen Falls After Japan PM Takaichi Comments
The Japanese yen weakened against other major currencies in the Asian session on Wednesday, as Japan's Prime Minister Sanae Takaichi signals a looser fiscal target and calls for caution in the Bank of Japan (BoJ) rate hike.
RTTNews
|
Před 3 h 57 min
